Skip to main content
. 2020 Mar 13;9(10):3337–3343. doi: 10.1002/cam4.2986

FIGURE 2.

FIGURE 2

Combination therapy‐induced growth inhibition in the patient‐derived xenograft. Combination therapy with oxaliplatin and 5‐fluorouracil (5‐FU), results in tumor growth inhibition rate of 0.84 in the PDXs. Eight tumors from five mice were assessed. Oxaliplatin +5‐FU treatment shows statistically significant growth inhibition compared to the control group (P = .004). P* indicated P < .05